Clinical Laserthermia Systems AB (publ) Total Assets
Clinical Laserthermia Systems AB (publ) total assets. Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) holds total assets worth Skr66.57 Million SEK (≈ $7.16 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Clinical Laserthermia Systems AB (publ) (CLS-B) total market value for the company's overall valuation and market capitalisation.
Total Assets of Clinical Laserthermia Systems AB (publ) (2008–2025)
Total assets of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. This chart illustrates how Clinical Laserthermia Systems AB (publ)'s total assets have evolved over time, based on quarterly financial data. See CLS-B stock price for real-time trading data and today's change.
Clinical Laserthermia Systems AB (publ) - Asset Composition Analysis
Clinical Laserthermia Systems AB (publ) Total Assets Breakdown (December 2025)
Clinical Laserthermia Systems AB (publ) total assets breakdown as of December 2025. Clinical Laserthermia Systems AB (publ)'s total assets of Skr66.57 Million consist of 51.2% current assets and 48.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 28.2% |
| Accounts Receivable | Skr4.88 Million | 6.4% |
| Inventory | Skr12.70 Million | 16.6% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr11.29 Million | 14.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2008–2025)
This chart illustrates how Clinical Laserthermia Systems AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CLS-B working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Clinical Laserthermia Systems AB (publ)'s current assets represent 51.2% of total assets in 2025, an increase from 40.4% in 2008.
- Cash Position: Cash and equivalents constituted 28.2% of total assets in 2025, down from 36.1% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 56.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 16.6% of total assets.
Clinical Laserthermia Systems AB (publ) Competitors by Total Assets
Key competitors of Clinical Laserthermia Systems AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Clinical Laserthermia Systems AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.94 | 4.49 | 1.41 |
| Quick Ratio | 0.59 | 3.97 | 1.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-1.59 Million | Skr26.74 Million | Skr16.88 Million |
Clinical Laserthermia Systems AB (publ) - Advanced Valuation Insights
This section examines the relationship between Clinical Laserthermia Systems AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.02 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -2.6% |
| Total Assets | Skr76.49 Million |
| Market Capitalization | $9.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Clinical Laserthermia Systems AB (publ)'s assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Clinical Laserthermia Systems AB (publ)'s assets decreased by 2.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below shows the annual total assets of Clinical Laserthermia Systems AB (publ) from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr76.49 Million ≈ $8.23 Million |
-2.64% |
| 2024-12-31 | Skr78.56 Million ≈ $8.45 Million |
+36.10% |
| 2023-12-31 | Skr57.73 Million ≈ $6.21 Million |
+16.60% |
| 2022-12-31 | Skr49.51 Million ≈ $5.33 Million |
-25.82% |
| 2021-12-31 | Skr66.74 Million ≈ $7.18 Million |
+50.31% |
| 2020-12-31 | Skr44.40 Million ≈ $4.78 Million |
+14.82% |
| 2019-12-31 | Skr38.67 Million ≈ $4.16 Million |
-33.36% |
| 2018-12-31 | Skr58.02 Million ≈ $6.24 Million |
+29.11% |
| 2017-12-31 | Skr44.94 Million ≈ $4.84 Million |
+64.59% |
| 2016-12-31 | Skr27.30 Million ≈ $2.94 Million |
+22.62% |
| 2015-12-31 | Skr22.27 Million ≈ $2.40 Million |
-39.74% |
| 2014-12-31 | Skr36.95 Million ≈ $3.98 Million |
+26.56% |
| 2013-12-31 | Skr29.20 Million ≈ $3.14 Million |
+45.54% |
| 2012-12-31 | Skr20.06 Million ≈ $2.16 Million |
+54.26% |
| 2011-12-31 | Skr13.01 Million ≈ $1.40 Million |
+10.56% |
| 2010-12-31 | Skr11.76 Million ≈ $1.27 Million |
+43.41% |
| 2009-12-31 | Skr8.20 Million ≈ $882.69K |
+48.50% |
| 2008-12-31 | Skr5.52 Million ≈ $594.40K |
-- |
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more